Old Web
English
Sign In
Acemap
>
authorDetail
>
Majed Charaan
Majed Charaan
Pfizer
Medicine
Internal medicine
Myeloid leukemia
Azacitidine
Oncology
4
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in Canada.
2021
Journal of Medical Economics
Yannan Hu
Majed Charaan
Ilse van Oostrum
Bart Heeg
Timothy J Bell
Show All
Source
Cite
Save
Citations (1)
The comparative effectiveness of glasdegib in combination with low-dose cytarabine versus azacitidine by bone marrow blasts counts among patients with newly-diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
2020
Journal of Clinical Oncology
Sophie van Beekhuizen
Yannan Hu
Ana Gezin
Bart Heeg
Timothy J Bell
Majed Charaan
Andrew Brown
Geoffrey Chan
Joseph C. Cappelleri
Show All
Source
Cite
Save
Citations (2)
Overall Survival of Glasdegib in Combination with Low-Dose Cytarabine and Azacitidine By Bone Marrow Blasts Among Adult Patients with Previously Untreated Acute Myeloid Leukemia: Comparative Effectiveness Using Indirect Treatment Comparisons
2019
Blood
Sophie van Beekhuizen
Timothy J Bell
Ana Gezin
Joseph C. Cappelleri
Bart Heeg
Carl Selya-Hammer
Majed Charaan
Geoffrey Chan
Show All
Source
Cite
Save
Citations (0)
The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review
2019
Blood
Tayler Scory
Eileen Shaw
Tara Cowling
Francois Peloquin
Verna L. Welch
Majed Charaan
Andrew Brown
Show All
Source
Cite
Save
Citations (0)
1